个性化癌症免疫疗法通过cGAS-STING向纳米疫苗增强,与营养素调制相结合
Wenping Huang1,2,3, Guoliang Cao1, Mixiao Tan1
1CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety CAS Center for Excellence in Nanoscience National Center for Nanoscience and Technology Beijing China.
Exploration (Beijing, China)
|January 1, 2026
概括
基因工程细菌产生循环二核酸 (STING激动剂) 用于癌症免疫疗法. 个性化纳米疫苗 (nECT) 增强免疫反应,重塑瘤微环境,显示出瘤治疗的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 循环二核酸激活STING通路,对于癌症免疫治疗中的免疫反应至关重要.
- 目前的局限性包括周期性二核酸的稳定性和输送不佳,阻碍了它们的治疗用途.
研究的目的:
- 开发一种使用工程细菌的新型纳米疫苗 (nECTs),用于增强癌症免疫治疗.
- 评估nECT在刺激免疫反应和重塑瘤微环境方面的有效性.
主要方法:
- 用基因工程*大肠杆菌*在细胞内产生2'3'-cGAMP.
- 通过将工程细菌与自身瘤抗原相结合,制造出个性化纳米疫苗 (nECT).
- 评估了nECT在体外对树突细胞活性和通过STING信号的抗原交叉呈现的影响.
- 在小鼠模型中评估nECT的体内疗效,包括与类似禁食饮食的组合.
主要成果:
- 在体外,nECT有效地刺激了树突细胞活性和抗原交叉呈现.
- 在体内,nECT疫苗接种促进了T细胞透和IFN-β介导的瘤微环境的重塑.
- 结合nECTs与模仿禁食的饮食,协同增强了治疗疗效.
结论:
- 个性化纳米疫苗 (nECTs) 通过利用工程细菌和STING激活,为癌症免疫疗法提供了一个有希望的策略.
- 结合治疗的nECTs和禁食模仿饮食显示出在瘤学中提高精度和有效性的潜力.
更多相关视频
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
926
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
926
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


